Select a medication above to begin.
safran des Indes
turmeric (Curcuma longa)
Reported Doses
Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely
Special Note, COVID-19
- [no scientific data for COVID-19]
- Info: see Herb & Supplement Remedy Use in COVID-19 Resources
Special Note
- [formulation clarification]
- Info: extracts generally stdzd to contain 75-100% curcuminoid content
Effectiveness Ratings
- [see Herb & Supplement Effectiveness Rating Definitions table]
acral erythema, chemo-induced
- [Insufficient Evidence]
- Dose: 4 g PO qd; Alt: apply 0.5% curcumin extract ointment topically bid starting day 1 of chemo
allergic rhinitis
- [Possibly Effective]
- Dose: 500 mg PO qd
aphthous ulcer (canker sores)
- [Insufficient Evidence]
- Dose: apply 2% gel topically qd; Alt: apply 1% nanomicelle gel topically tid
asthma, peds pts
- [Insufficient Evidence]
- Dose: 20 mg/kg/day PO divided bid in pts 7-10 yo; 30 mg/kg/day PO divided bid in pts 11-14 yo; 40 mg/kg/day PO divided bid in pts 15-18 yo; Info: used w/ standard tx
beta-thalassemia
- [Insufficient Evidence]
- Dose: 500 mg PO bid-tid
BPH
- [Insufficient Evidence]
- Dose: 2250 mg PO qd; Info: used w/ tamsulosin and finasteride
CABG
- [Insufficient Evidence]
- Dose: 1 g PO qid; Start: 3 days before surgery
carpal tunnel syndrome
- [Insufficient Evidence]
- Dose: apply 1% curcuminoid gel topically bid
cognitive decline, age-related
- [Insufficient Evidence]
- Dose: 90 mg PO bid
colorectal CA prevention
- [Insufficient Evidence]
- Dose: 4 g PO qd
COVID-19
- [Insufficient Evidence]
- Dose: 525 mg PO bid; Alt: 80 mg PO bid; 240 mg/day PO divided qid; 1000 mg PO qd
Crohn dz
- [Insufficient Evidence]
- Dose: 1.08-1.44 g PO qd
denture stomatitis
- [Insufficient Evidence]
- Dose: apply gel topically tid
depression
- [Possibly Effective]
- Dose: 500 mg PO qd-bid; Info: used w/ or w/o standard tx
diabetes mellitus
- [Insufficient Evidence]
- Dose: 46-1670 mg PO qd
diabetic nephropathy
- [Insufficient Evidence]
- Dose: 66.3-1670 mg PO qd
dysmenorrhea
- [Insufficient Evidence]
- Dose: 266 mg PO x1; Start: on day of menstruation; Info: used w/ boswellia
dyspepsia
- [Possibly Effective]
- Dose: 500 mg PO qd-qid; Alt: 250-500 mg PO tid given after meals
exercise-induced muscle soreness
- [Insufficient Evidence]
- Dose: 2.5 g PO bid starting 2.5 days before exercise; Alt: 266 mg PO x1; 500 mg PO x1 immediately after exercise, then 500 mg PO x1 at 12h, then 500 mg PO x1 at 36h
gingivitis
- [Insufficient Evidence]
- Dose: 20 mL (0.05-20% mouthwash) swish/spit bid; Alt: 80 mg PO qd
Gulf war syndrome
- [Insufficient Evidence]
- Dose: 500 mg PO bid
hyperlipidemia
- [Possibly Effective]
- Dose: 80-4000 mg PO qd
IBS
- [Insufficient Evidence]
- Dose: 72-144 mg PO qd; Alt: 42 mg PO bid; Info: used w/ or w/o conventional tx
impaired glucose tolerance
- [Insufficient Evidence]
- Dose: 500 mg PO qd; Alt: 750 mg PO bid; 500 mg PO bid (extract ratio 1:2 turmeric:Indian gooseberry)
joint pain
- [Insufficient Evidence]
- Dose: 50 mg/day PO divided tid
knee pain
- [Insufficient Evidence]
- Dose: 250 mg PO qd
lichen planus
- [Insufficient Evidence]
- Dose: 2 g PO tid; Alt: 80 mg PO qd
metabolic syndrome
- [Insufficient Evidence]
- Dose: 80-2400 mg/day PO divided qd-tid; Alt: 630 mg PO tid; 25 mg PO bid
migraine prophylaxis
- [Insufficient Evidence]
- Dose: 500 mg PO bid
nausea/vomiting, chemo-induced
- [Insufficient Evidence]
- Dose: 500 mg PO bid
nonalcoholic fatty liver dz
- [Possibly Effective]
- Dose: 70 mg curcumin PO qd; Alt: 250-500 mg phytosomal curcumin PO qd-bid; 1 g turmeric rhizome pwdr PO tid; 500 mg curcumin PO qd-tid
oral mucositis, chemo- or XRT-related
- [Possibly Effective]
- Dose: 500 mg PO bid-tid; Alt: 80 mg PO bid; 40 mg PO qd; 10 mL (0.5% solution) swish/spit 6x/day; 10 mL (0.1% mouthwash) swish/spit tid
oral submucous fibrosis
- [Insufficient Evidence]
- Dose: 300 mg PO tid plus 0.1% w/v mouthwash swish/spit bid; Alt: 300-400 mg PO qd; apply 5 mg gel topically in divided doses 3-4x/day; apply 10 g paste in 10 mL honey topically qid
osteoarthritis
- [Possibly Effective]
- Dose: 40-100 mg PO bid; Alt: 500 mg PO bid-qid; 1500 mg PO qd; apply 5% ointment topically bid; apply 1.5 g nano-emulsion gel topically bid
pain, acute
- [Insufficient Evidence]
- Dose: 266 mg PO qd; Info: used w/ boswellia
periodontitis
- [Insufficient Evidence]
- Dose: apply 2% curcumin gel topically qd; Alt: 2 mg curcumin gel applied to mouth; 80 mg PO qd
peripheral neuropathy, chemo-induced
- [Insufficient Evidence]
- Dose: 500 mg PO bid
polycystic ovary syndrome
- [Insufficient Evidence]
- Dose: 500 mg PO qd-tid; Alt: 80 mg PO qd
postop pain
- [Insufficient Evidence]
- Dose: 1.2-2 g/day PO divided tid-qid; Alt: 200 mg PO x1
premenstrual syndrome
- [Insufficient Evidence]
- Dose: 100 mg PO bid; Info: start 7 days before menstruation, cont. 3 days after menstruation
prostate CA
- [Insufficient Evidence]
- Dose: 1.8 g PO tid
pruritus
- [Possibly Effective]
- Dose: 1-1.5 g/day PO divided qd-tid
psoriasis
- [Insufficient Evidence]
- Dose: turmeric tonic applied to scalp 2x/day
quality of life
- [Insufficient Evidence]
- Dose: 500-2250 mg PO qd; Alt: 42 mg PO bid; turmeric tonic applied to scalp 2x/day
radiation dermatitis
- [Insufficient Evidence]
- Dose: 500-2000 mg PO tid; Alt: 80 mg PO bid; apply 500 mg curcumin gel topically tid; apply turmeric cream topically 5x/day during radiation tx
rheumatoid arthritis
- [Insufficient Evidence]
- Dose: 500-1200 mg/day PO divided bid-tid
sarcopenia
- [Insufficient Evidence]
- Dose: 500 mg PO qd; Info: slow-release product
SLE
- [Insufficient Evidence]
- Dose: 500 mg PO tid
smoking cessation
- [Insufficient Evidence]
- Dose: 50 mg PO qd
stress
- [Insufficient Evidence]
- Dose: 500 mg PO bid
stroke
- [Insufficient Evidence]
- Dose: 500 mg PO qd
tuberculosis
- [Insufficient Evidence]
- Dose: 500 mg PO bid
ulcerative colitis
- [Insufficient Evidence]
- Dose: 0.5-3 g PO qd; Alt: 140 mg/20 mL enema PR qd
uveitis
- [Insufficient Evidence]
- Dose: 60 mg PO bid x12mo; Info: used w/ standard corticosteroid tx in first 6mo of tx
Copyright © 2024. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.